











































































Cost Effectiveness of the Earned Income
Tax Credit as a Health Policy Investment
Peter A. Muennig, MD, MPH,1 Babak Mohit, MPH, MBA, PhD,1 Jinjing Wu, PhD,1 Zohn Rosen, PhD,1
Haomiao Jia, PhD2Q1
Introduction: Lower-income Americans are suffering from declines in income, health, and
longevity over time. Income and employment policies have been proposed as a potential non-
medical solution to this problem.
Methods: An interrupted time series analysis of state-level incremental supplements to the Earned
Income Tax Credit (EITC) program was performed using data from 1993 to 2010 Behavioral Risk
Factor Surveillance System surveys and state-level life expectancy. The cost effectiveness of state
EITC supplements was estimated using a microsimulation model, which was run in 2015.
Results: Supplemental EITC programs increased health-related quality of life and longevity among
the poor. The program costs about $7,786/quality-adjusted life-year gained (95% CI¼$4,100,
$13,400) for the average recipient. This ratio increases with larger family sizes, costing roughly
$14,261 (95% CI¼$8,735, $19,716) for a family of three.
Conclusions: State supplements to EITC appear to be highly cost effective, but randomized trials
are needed to confirm these findings.
(Am J Prev Med 2016;](]):]]]–]]]) & 2016 American Journal of Preventive Medicine. Published by Elsevier Inc.
All rights reserved.
Introduction
Starting in the 1990s, lower-income Americansbegan to realize a gradual decline in health,followed by a decline in life expectancy.1–5 This
trend among lower-income Americans is historically
unprecedented in a nation that is not confronting a
catastrophe, such as the fall of the Soviet Union or the
HIV/AIDS crisis in sub-Saharan Africa of the 1990s.6 In
parallel with this trend, skyrocketing healthcare costs and
declining wages have been eroding the standard of living
among low- and middle-income households in the U.S.7
If these confluent health and macroeconomic stressors
continue, the U.S. may be faced with a future in which the
tide of increasing prosperity and health throughout much
of the 20th century, for lower middle class Americans,
slowly recedes.
Poverty is believed to be a major risk factor for poor
health.8,9 Poverty is independently associated with a
larger burden of disease than obesity or smoking.10 It
may therefore be possible to improve the health and
increase the longevity of lower-income Americans with
anti-poverty programs.11–13 Such programs can improve
the standard of living of lower-income Americans,
thereby reducing exposure to crime, stress, poor housing,
and cheap processed foods. In this conceptualization,
poverty is an “upstream” risk factor for an array of other
risk factors that produce much of the disease and death in
America. If poverty damages one’s health, then anti-
poverty programs targeted toward younger, healthy
workers might conceivably function as a primary pre-
vention “vaccine” against a downward spiral of poverty
and poor health.14–17
One social welfare program, the Earned Income Tax
Credit (EITC), designed to boost both income and
employment, has lifted 7 million Americans out of
poverty and has received bipartisan support.18–20 Pres-
ently, 27 states supplement the federal program with
their own “supplemental” EITC.
However, the association between EITC receipt and
health or longevity has not been proven, the program is
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expensive, and there is some evidence that it might
increase the BMI of some low-income Americans.9,21
There are proposals presently in Congress aimed at
expanding EITC, particularly to childless workers, but
these proposals have not yet been funded despite support
by both parties.22 In this study, causal modeling of state
EITC supplementation on health was therefore con-
ducted and these data were entered into a microsimula-
tion model to determine whether supplementation is a
cost-effective way to improve population health.
Methods
Overview
These analyses are described in detail in the Appendix (available
online), which includes additional introductory text, the date of
implementation, magnitude of the EITC increase by state, dose–
response analyses, analyses by each state, further details of the
methods, and additional results.23–25
To estimate the effect of state-level EITC supplementation on
health, an interrupted time series difference-in-difference analysis
of state-level mortality rates and health-related quality of life
(HRQL) scores was conducted between 1980 and 2011. With the
average change in HRQL and mortality rates across all states that
supplemented EITC, it is possible to estimate the number of
quality-adjusted life-years (QALYs, or years of life lived in perfect
health).26 Note that EITC recipients are a high-risk population for
premature mortality, and comprise upwards of one in ten people
in each state. They are therefore responsible for a disproportionate
share of annual mortality changes in a given state. Each outcome
measure (HRQL and mortality rate) was estimated as the net,
weighted mean effect across states that supplemented the federal
EITC relative to before supplementation. The effect was also
estimated relative to states that did not supplement over the period
of interest—from 1980 to 2011. The analysis did not account for
the magnitude of the supplement in individual states, but rather
the binary effect (supplement or no supplement).
The effects by state and the effect by the size of the supplement
were estimated in a secondary analysis. These estimates are
associational, and therefore represent a weaker estimation
approach (Appendix, available online). In theory, it is possible to
account for these effects using an instrumental variable approach
(yielding an estimate that is less subject to confounding), but the
sample size was inadequate for such an analysis.
The cost of the EITC supplemental programs was evaluated
using estimates of deadweight loss associated with tax transfers.27
In this case, deadweight loss is an estimate of economic inefficiency
produced when tax dollars are used to supplement labor income.
The cost-effectiveness analysis followed the recommendations of
the Panel on Cost-Effectiveness in Health and Medicine, and
employed a 3% rate of discount for future costs and QALYs
gained.26 The model input parameters are presented inT05 Table 1.
The model assumed that deadweight loss was correctly estimated,
that the interrupted time series (quasi-experimental) analyses of
EITC implementation by state correctly estimated their health
impacts, and that EITC did not impact other costs (e.g., health
expenditures).
Mortality and Health-Related Quality of Life
Two data sources were used to estimate the change in quality-
adjusted life expectancy (QALE) associated with EITC expansion:
(1) state-level Behavioral Risk Factor Surveillance System (BRFSS)
data from 1993 to 2011 to obtain annual state-level age-adjusted
HRQL and (2) the annual state-level age-adjusted mortality data
from 1980 to 2011 from the Compressed Mortality File to calculate
annual state-specific life expectancy.27–29 The models were run in
November 2015. Responses to questions within the BRFSS were
mapped to the EuroQol 5D (EQ-5D) index, an HRQL-compatible
measure.29 QALE was then estimated by first estimating that state-
level mortality rate and mean EQ-5D index in each age group and
then building life tables from these data.30–33
Because the BRFSS and the Compressed Mortality File cover












































































































Table 1. Input Values for the Microsimulation Model and the
Associated Range of Error




Earned income tax credita
Average $2,440
0 children $496 —
1 child $3,305 —
2 children $5,460 —





State life expectancy Annual, age-
specific
—
Annual change in QALEb
Average 0.097 0.020
0 childrenc 0.069 —c
1 childc 0.087 —c
2 childrenc 0.097 —c
Z3 childrenc 0.126 —c
aThe cost of the EITC by family size is calculated by multiplying the
average returns by the deadweight loss ratio.
bThe annual change in QALE for recipients of EITC in states that
expanded their EITC programs. The QALE is calculated using spatio-
temporal differences in mapped EuroQol 5D (EQ5D) scores in states
that did and did not expand EITC and is statistically significant at
po0.0001.
cAnnual variation in life expectancy by family size is not available at the
state level. The annual QALE gained was estimated using linear
interpolation of HRQL scores under the assumption that life expectancy
is directly proportional to HRQL.
EITC, earned income tax credit; HRQL, health-related quality of life;
QALE, quality-adjusted life expectancy.
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two analyses (HRQL and mortality rates) are not strictly com-
parable. Twenty-seven states have implemented a supplemental
EITC policy, with states implementing these policy changes at
different points in time (T10 Table 2). Usable mortality data were
available for 26 states and usable HRQL data for 22 states.
Mortality data were excluded for Cal-
ifornia because its EITC program was
implemented in 2015, resulting in
inadequate follow-up time. HRQL
data were excluded for Colorado,
Connecticut, Ohio, and Virginia
because the survey design and sam-
pling frame of the BRFSS were
changed within the period of interest,
potentially explaining any observed
change in HRQL. Colorado’s mortal-
ity rates are also potentially attenuated
because EITC was enacted in 1999 but
withdrawn in 2001. It was re-enacted
in 2013, but this date was out of the
range of Q4this analysis QT15Table 3.
Statistical Analysis
An interrupted time series analysis
was conducted using SAS, version
9.4. There were 51 states from 1993
to 2008, yielding 51 " 16 ¼ 816 data
points, or 51 series of data, one for
each state. The slope in the annual
change in QALE was observed for
each of the 51 states, and the annual
change in QALE was observed before
and after EITC implementation for 22
states for HRQL and 26 states for
mortality. Thus, data were collapsed
across different numbers of states,
depending on the outcome measure,
to compute the mean effects for each
outcome measure. The mean effect of
EITC implementation was estimated
separately for HRQL and for mortality
as follows:
Let yi;t be the health outcome meas-
ure for state i at year t. Suppose binary
variable I is an indicator for the
implementation of EITC and variable
t2 is the number of years since the
implementation of EITC and t2¼0 for
years before the implementation. The
following model was applied:
Eðyi;tÞ¼β0iþβ1itþβ2iIþβ3it2þβ4X;
where X is a set of possible confound-
ing variables (used only in sensitivity
analyses) and βji (j¼0, 1, 2, 3) are the
state-specific random coefficients to
incorporate differences across states.
To examine the impact of EITC, β2i
and β3i were estimated for the changes on level and slope,
respectively. In sum, the slope was computed for each state prior
to and after implementation of EITC by examining the interaction
term of EITC on each of the outcome measures of interest.
The statistical approach was validated in a number of ways.












































































































Table 2. Supplemental EITC Benefit by State, Year Enacted, and Change in Slope in





(% addition to Federal EITC)
Increase in
QALE
California 2015 85 —a
Colorado 1999, 2013 10 —b,c
Connecticut 2011 27.5 —b
Delaware 2005 20 –0.017
District of Columbia 2000 40 –0.057
Illinois 2000 10 0.261
Indiana 1999 9 0.045
Iowa 1989 15 0.117
Kansas 1998 17 0.054
Louisiana 2007 3.5 0.049
Maine 2000 5 –0.016
Maryland 1987 25.5 0.029
Massachusetts 1997 23 0.070
Michigan 2006 6 0.398
Minnesota 1991 35 0.114
Nebraska 2006 10 0.247
New Jersey 2000 30 0.008
New Mexico 2007 10 0.150
New York 1994 30 0.227
Ohio 2013 10 —b
Oklahoma 2002 5 0.807
Oregon 1997 8 –0.096
Rhode Island 1986 12.5 0.062
Vermont 1988 32 0.090
Virginia 2004 20 —b
Washington 2000 10 0.067
Wisconsin 1989 11 0.074
aThe EITC program was enacted too recently to capture meaningful health outcomes.
bThe Behavioral Risk Factor Surveillance System data set that was used to estimate HRQL gains
changed the sampling frame within the period of interest, so these states were only used in the analysis
of mortality rates. Overall QALE was generated using mean HRQL effects from 22 states and mean
mortality rate effects from 26 states.
cThe state EITC program existed for only 2 years (between 1999 and 2001) before being re-enacted in
2013. We attempted to capture the 2 years of program effects on mortality between 1999 and 2001.
EITC, earned income tax credit; HRQL, health-related quality of life; QALE, quality-adjusted life expectancy.
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changes in QALE between 1980 and 2011 (Appendix [available
online] shows a complete list of states.) Table 2 in this paper shows
changes in QALE by state prior to and after implementation of the
EITC (by the year enacted) for those states that adopted EITC. In
this table, the change in slope of QALE after enactment of EITC
was positive in the vast majority of states that adopted supple-
mental EITC. Adopting states that had negative slopes tended to
have relatively small supplements to EITC. The marginal QALE
values presented in Table 2 represent the marginal gain in QALE
by state computed by obtaining the simple, undiscounted product
of marginal HRQL and marginal life expectancy changes. The
primary analysis estimates these values over the remaining life
span of the average EITC recipient at a 3% rate of discount.
Second, dose–response effects were estimated by ordinary least
squares analysis to ensure that higher state-level supplements were
associated with the outcomes of interest. Similarly, an analysis of
the association between family size and health effects was modeled.
This analysis not only provides policymakers with information on
the differential impacts of EITC supplementation by family size,
but also serves to validate the model because larger families receive
disproportionately large EITC supplements.
Markov Model
A simple microsimulation model was built using 10,000 random
walk trials (model finalized November 11, 2015). In the control
arm, the status quo (baseline receipt of federal EITC) was
estimated by exposing each hypothetical participant to their age-
specific probability of death during each 1-year cycle in the model
as derived from an unabridged U.S. life table.34 Participants who
“died,” exited the model and participants who “survived” exposure
to this probability of death remained in the model. This approach
was validated using the life table approach.35
In the supplemental EITC arm, the model also accounted for
annual losses associated with transfers of cash from better-off
groups to the poor (deadweight loss)27 and annual incremental
changes in QALE associated with EITC supplementation. Changes
in healthcare utilization were not estimated. The inclusion of
healthcare system costs may alter the social costs of EITC (either
increasing them or decreasing them).
Even after accounting for years in which recipients are ineligible,
recipients who do not file for EITC, and discounting, the very small
annual increases in QALE among states that implement EITC can
become substantial. This is because these effects are calculated
from the time of EITC receipt until death for the average recipient.
Payments to EITC recipients are known with relative precision
and accuracy (as they are based on Internal Revenue Service
claims), as are age-specific probabilities of mortality from age 25
years (the age at which EITC starts for most recipients) through
age 65 years (as they are based on all deaths in the U.S.). Therefore,
the most likely sources of significant error in the model are
estimates of deadweight loss (non-random) and QALE (based
upon sampling error in the BRFSS and state-to-state variability for
EITC expansion states). To test the sensitivity of the assumptions
presented here, deadweight loss error was modeled using a
triangular distribution with a mean of 30% and endpoints at
15% and 45% to ensure a wide range of plausible values. The





















































































































Average recipient (95% CI) 16371 (10058, 22765) 2.2 (1.4, 3.1) 7686 (4053, 13392)
Family size (95% CI)
No children 3298 (2001, 4579) 1.6 2107 (1279, 2925)
1 child 21963 (13401, 30574) 2.0 11054 (6745, 15389)
2 children 36182 (22206, 50363) 2.2 16404 (10068, 22834)
3 children 40865 (25031, 56496) 2.9 14261 (8735, 19716)
One-way sensitivity analysesb
Deadweight loss
15% 16189 2.2 7666
45% 24311 2.2 11530
Discount rate
0% 27388 3.7 7732
5% 12187 1.6 7675
aThe incremental cost-effectiveness ratio represents the change in costs divided by the change in QALYs gained among states that supplemented the
EITC relative to states that did not supplement the EITC. All analyses are discounted at 3% unless otherwise indicated. By convention, all
effectiveness values are rounded to the nearest 0.1 decimal place.
bBased on the average micro-simulation model.
EITC, earned income tax credit; QALYs, quality-adjusted life-years.
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